OCCAM BCI, INC. (Website: Not publicly available) recently secured a major technological breakthrough with the issuance of U.S. Patent No. 12721564. This patent, titled ‘Wearable sensor’, introduces a powerful way to monitor physiological and brain signals. Inventors André Filipe Marques-Smith and Ana Montero Horas have designed a skin conformable and compact electronic apparatus that tracks vital metrics with precision.
Advanced Monitoring for Physiological Signals
The innovation focuses on a new skin conformable design for wearable electronics. This system uses specialized materials to provide a comfortable fit while maintaining a strong connection to the skin of the user. A compact apparatus within the device receives and processes intricate brain and physiological data. This precision engineering ensures the sensor stays securely attached to capture accurate readings. This setup allows for continuous health monitoring without disrupting the daily activities of the wearer.
Delaware Patent of the Month for October 2026
This invention won the patent of the month for the Delaware state for the month of October 2026 granted by Swanson Reed because of its exceptional engineering and potential to advance non invasive neurotechnology. The award committee recognized Occam BCI for demonstrating outstanding technical merit by miniaturizing complex brain computer interface components into a simple wearable patch. This advancement stood out for its immediate commercial viability and its practical implications for medical diagnostics and consumer health devices.
R&D Tax Credit Eligibility in the USA
The practical applications of this patent might be applied to be eligible for an R&D tax credit in the USA. The engineering efforts required to iterate on the materials science for a skin conformable apparatus, along with the software development for processing brain signals, involve resolving substantial technical uncertainty. Companies investing resources to improve signal resolution, test different biocompatible adhesives, or develop algorithms that interpret these complex physiological signals can qualify for these tax incentives. The iterative testing processes and prototyping involved in scaling such a wearable sensor from a lab concept to consumer ready hardware align directly with the criteria of the four part test used by the IRS to determine R&D credit eligibility.
